IL-6 upregulates the phosphatidylinositol 3-kinase (PI3K)- protein kinase B (AKT) pathway, one of the key pathways commonly activated during tumor development in both CAC and CRC [40,41,42]. Here, AKT1 is linked to neoplasm.